Groups launch last-ditch effort against drug pricing changes - Roll Call Interest groups are spending millions in hopes of blocking legislation allowing Medicare to demand lower prices for prescription drugs. Roll Call · Jul 29, 2022
Partisan lines form over Dem drug price curbs, economic plan Senate Minority Leader Mitch McConnell says plans by Democrats to curb drug prices would place socialist price controls between Americans and the treatments they need The Independent UK · Jul 19, 2022
As drugmakers cut off discounts, providers fret for low-income patients Hospitals and community and rural health clinics that serve low-income patients say drug manufacturers have threatened their financial stability by dramatically cutting back their participation in a federal drug discount program that saves those health providers millions of dollars a year. Tribune News Service · Jul 3, 2022
Gaetz inaccurate diagnosis of insulin Health economists and diabetes experts weigh in on Gaetz’s faulty cause-and-effect argument that "doesn't exist" Salon · May 1, 2022
Fact check: Rep. Gaetz’s diagnosis of what’s driving insulin costs misses the root cause At the end of March, after the House passed a bill that would cap the cost of insulin at $35 per month for insured consumers, Rep. Matt Gaetz, R-Fla., tweeted about why he voted against the legislation. Tribune News Service · Apr 25, 2022